Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017882/?tool=EBI |
| _version_ | 1817984396174557184 |
|---|---|
| author | Hitoshi Tajiri Satoshi Motoya Fukunori Kinjo Atsuo Maemoto Takayuki Matsumoto Noriko Sato Hiroshi Yamada Mieko Nagano Yutaka Susuta Kunihiko Ozaki Kazuoki Kondo Toshifumi Hibi |
| author_facet | Hitoshi Tajiri Satoshi Motoya Fukunori Kinjo Atsuo Maemoto Takayuki Matsumoto Noriko Sato Hiroshi Yamada Mieko Nagano Yutaka Susuta Kunihiko Ozaki Kazuoki Kondo Toshifumi Hibi |
| author_sort | Hitoshi Tajiri |
| collection | DOAJ |
| first_indexed | 2024-04-13T23:45:03Z |
| format | Article |
| id | doaj.art-19fa0a9f69874c2db3a458026de01630 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T23:45:03Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-19fa0a9f69874c2db3a458026de016302022-12-22T02:24:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01174Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in JapanHitoshi TajiriSatoshi MotoyaFukunori KinjoAtsuo MaemotoTakayuki MatsumotoNoriko SatoHiroshi YamadaMieko NaganoYutaka SusutaKunihiko OzakiKazuoki KondoToshifumi Hibihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017882/?tool=EBI |
| spellingShingle | Hitoshi Tajiri Satoshi Motoya Fukunori Kinjo Atsuo Maemoto Takayuki Matsumoto Noriko Sato Hiroshi Yamada Mieko Nagano Yutaka Susuta Kunihiko Ozaki Kazuoki Kondo Toshifumi Hibi Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan PLoS ONE |
| title | Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan |
| title_full | Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan |
| title_fullStr | Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan |
| title_full_unstemmed | Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan |
| title_short | Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan |
| title_sort | correction infliximab for pediatric patients with crohn s disease a phase 3 open label uncontrolled multicenter trial in japan |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017882/?tool=EBI |
| work_keys_str_mv | AT hitoshitajiri correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT satoshimotoya correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT fukunorikinjo correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT atsuomaemoto correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT takayukimatsumoto correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT norikosato correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT hiroshiyamada correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT miekonagano correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT yutakasusuta correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT kunihikoozaki correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT kazuokikondo correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan AT toshifumihibi correctioninfliximabforpediatricpatientswithcrohnsdiseaseaphase3openlabeluncontrolledmulticentertrialinjapan |